# CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway

_Oncology Research · Shi Zong, Kaichen Wang, Yonggang Wang · 2026_

Canonical: https://diginpl.com/books/paper-or-2026-084842
Last updated: 2026-10-14

## Quick facts

- **Author:** Shi Zong; Kaichen Wang; Yonggang Wang ([Crossref](https://doi.org/10.32604/or.2026.084842))
- **Published:** 2026 ([Crossref](https://doi.org/10.32604/or.2026.084842))
- **Publisher:** Tech Science Press ([Crossref](https://doi.org/10.32604/or.2026.084842))
- **Journal:** Oncology Research ([Crossref](https://doi.org/10.32604/or.2026.084842))
- **DOI:** 10.32604/or.2026.084842 ([Crossref](https://doi.org/10.32604/or.2026.084842))

## Questions

**Who wrote CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway?**  
CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway was written by Shi Zong, Kaichen Wang, Yonggang Wang.

**When was CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway first published?**  
CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway was first published in 2026.

## Sources

- [Publisher record (DOI, via Crossref)](https://doi.org/10.32604/or.2026.084842)

## Licence and attribution

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.084842.

## Cite this page

"CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway". DigiNepal. Last updated 14 October 2026. https://diginpl.com/books/paper-or-2026-084842. Retrieved 14 November 2026.